Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1980-07-07
1983-07-26
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424251, 536 23, 544303, 544311, 544313, 544315, 544316, 544318, A61K 31505, C07D23936, C07D23956
Patent
active
043954065
ABSTRACT:
Novel derivatives of pyrimid-2-one having interesting pharmacological properties are described. The compounds of the invention have been found to be of use in the control of, and in particular in the inhibition of the metaphase of malignant tumours and leukaemias. Processes for the preparation of the novel compounds and pharmaceutical compositions containing them are also described.
REFERENCES:
patent: 3317532 (1967-05-01), Gamaliel et al.
patent: 3833586 (1974-09-01), Schwan et al.
patent: 4003900 (1977-01-01), Schwan
patent: 4014996 (1977-03-01), Maurer et al.
Stark, Annellen der Chemie, 381, pp. 143-155, (1911).
Ueda et al., J. Med. Chem., vol. 6, pp. 697-701.
Brown et al., Aust. J. Chem., 1968, vol. 21, pp. 243-255.
Gacek Mikkel J.
Laland Soren
Oftebro Reidar
Undheim Kjell
Coughlan, Jr. Paul M.
Nyegaard & Co. A/S
LandOfFree
5-Halopyrimid-2-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Halopyrimid-2-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Halopyrimid-2-ones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2221727